Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib

Eskandar Moghimipour 1 , 2 , Anayatollah Salami 1 , 2 , * and Mahsa Monjezi 2
Authors Information
1 Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2015, 10 (1); e17653
  • Published Online: February 20, 2015
  • Article Type: Research Article
  • Received: January 17, 2014
  • Revised: March 3, 2014
  • Accepted: August 17, 2014
  • DOI: 10.17795/jjnpp-17653

To Cite: Moghimipour E, Salami A, Monjezi M. Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib, Jundishapur J Nat Pharm Prod. 2015 ; 10(1):e17653. doi: 10.17795/jjnpp-17653.

Abstract
Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Hadgraft J, Lane ME. Skin permeation: the years of enlightenment. Int J Pharm. 2005; 305(1-2): 2-12[DOI][PubMed]
  • 2. Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008; 11(2): 81s-110s[PubMed]
  • 3. Seedher N, Bhatia S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS PharmSciTech. 2003; 4(3)[DOI][PubMed]
  • 4. Schoen RT, Vender RJ. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med. 1989; 86(4): 449-58[PubMed]
  • 5. Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995; 35(3): 209-19[PubMed]
  • 6. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum. 1998; 41(9): 1591-602[DOI][PubMed]
  • 7. Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm. 2007; 57(3): 315-32[DOI][PubMed]
  • 8. Ventura CA, Giannone I, Paolino D, Pistara V, Corsaro A, Puglisi G. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study. Eur J Med Chem. 2005; 40(7): 624-31[DOI][PubMed]
  • 9. Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Ther. 2001; 297(2): 638-45[PubMed]
  • 10. Paradkar AR, Chauhan B, Yamamura S, Pawar AP. Preparation and characterization of glassy celecoxib. Drug Dev Ind Pharm. 2003; 29(7): 739-44[DOI][PubMed]
  • 11. Clemett D, Goa KL. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs. 2000; 59(4): 957-80[PubMed]
  • 12. Davies NM, McLachlan AJ, Day RO, Williams KM. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet. 2000; 38(3): 225-42[DOI][PubMed]
  • 13. Walter MF, Jacob RF, Day CA, Dahlborg R, Weng Y, Mason RP. Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs. Atherosclerosis. 2004; 177(2): 235-43[DOI][PubMed]
  • 14. Paulson SK, Kaprak TA, Gresk CJ, Fast DM, Baratta MT, Burton EG, et al. Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human. Biopharm Drug Dispos. 1999; 20(6): 293-9[PubMed]
  • 15. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005; 352(11): 1071-80[DOI][PubMed]
  • 16. Pai RS, Devi KV. Lamivudine liposomes for Transdermal Delivery-Formulation, characterization, Stability, and In-vitro Evaluation. Int J Pharm Sci Nanotechnol. 2009; 1: 317-26
  • 17. Moghimipour E, Salimi A, Sharifmakhmalzadeh B. Effect of the Various Solvents on the In Vitro Permeability of Vitamin B 12 through Excised Rat Skin. Trop J Pharm Res. 2013; 12(5): 671-7
  • 18. Moghimipour E, Handali S. Utilization of thin film method for preparation of celecoxib loaded liposomes. Adv Pharm Bull. 2012; 2(1): 93-8[DOI][PubMed]
  • 19. Chetanachan P, Akarachalanon P, Worawirunwong D, Dararutana P, Bangtrakulnonth A, Bunjop M, et al. Ultrastructural Characterization of Liposomes Using Transmission Electron Microscope. Adv Mat Res. 2008; 55: 709-11[DOI]
  • 20. Mohammadi-Samani S, Montaseri H, Jamshidnejad M. Preparation and evaluation of cyproterone acetate liposome for topical drug delivery. Iran J Pharm Sci. 2009; 5(4): 199-204
  • 21. Padamwar MN, Pokharkar VB. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm. 2006; 320(1-2): 37-44[DOI][PubMed]
  • 22. Moghimipour E, Salimi A, Eftekhari S. Design and characterization of microemulsion systems for naproxen. Adv Pharm Bull. 2013; 3(1): 63-71[DOI][PubMed]
  • 23. Roberts MS, Cross SE. Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems. Inflammopharmacology. 1999; 7(4): 339-50[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments